MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$156K
Free Cash flow
$160K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Prepaid expenses and other curre...
Accrued liabilities
Impairment of intangible assets
Others
Negative Cash Flow Breakdown
Accounts receivable
Accounts payable
Operating lease liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Product sales
-
2,315
9,100
-
Cost of sales
-
954
4,033
-
General and administrative
-
1,122
3,532
-
Selling and marketing
-
273
1,118
-
Research and development
-
156
684
-
Total operating expenses
-
2,505
9,367
-
Loss from operations
-
-190
-267
-
Total other expense, net
-
-30
-151
-
Net loss
-71
-220
-348
57
Stock-based compensation
59
64
64
63
Depreciation and amortization
27
34
54
56
Non-cash operating lease expense
86
83
81
79
Interest expense on related party note payable
33
33
35
35
Change in inventory reserve
15
8
16
-26
Impairment of intangible assets
111
-
-
-
Accounts receivable
168
68
-292
-86
Inventories
-43
264
-71
-12
Prepaid expenses and other current assets
-129
135
19
-107
Accounts payable
-127
269
-97
-132
Accrued liabilities
128
413
-24
-199
Operating lease liabilities
-98
-96
-93
-89
Net cash provided by (used in) operating activities
167
121
32
49
Purchases of property and equipment
7
23
3
3
Payments for patent licenses
4
8
2
-
Net cash used in investing activities
-11
-31
-5
-3
Payments on related party note payable
0
150
0
0
Net cash used in financing activities
0
-150
0
0
Net increase (decrease) in cash
156
-60
27
46
Cash, beginning of period
933
993
966
1,230
Cash, end of period
1,089
933
993
966
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Prepaid expenses and
other current assets
-$129K
(-188.36%↓ Y/Y)
Accrued liabilities
$128K
(3.23%↑ Y/Y)
Impairment of intangible
assets
$111K
Non-cash operating lease
expense
$86K
(-42.67%↓ Y/Y)
Stock-based compensation
$59K
(-63.35%↓ Y/Y)
Inventories
-$43K
(-109.15%↓ Y/Y)
Interest expense on
related party note...
$33K
(-56.00%↓ Y/Y)
Depreciation and
amortization
$27K
(-75.23%↓ Y/Y)
Change in inventory
reserve
$15K
(-72.73%↓ Y/Y)
Net cash provided by
(used in) operating...
$167K
(328.77%↑ Y/Y)
Canceled cashflow
$464K
Net increase
(decrease) in cash
$156K
(150.32%↑ Y/Y)
Canceled cashflow
$11K
Accounts receivable
$168K
(290.70%↑ Y/Y)
Accounts payable
-$127K
(-160.19%↓ Y/Y)
Operating lease
liabilities
-$98K
(43.02%↑ Y/Y)
Net loss
-$71K
(44.09%↑ Y/Y)
Net cash used in
investing activities
-$11K
(70.27%↑ Y/Y)
Purchases of property and
equipment
$7K
(-81.08%↓ Y/Y)
Payments for patent
licenses
$4K
Buy us a coffee
International Stem Cell CORP (ISCO)
International Stem Cell CORP (ISCO)